Ziritaxestat
Product Specifications
UNSPSC Description
Ziritaxestat (GLPG1690) is a first-in-class autotaxin (ATX) inhibitor, with an IC50 of 131 nM and a Ki of 15 nM[1].
Target Antigen
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/GLPG1690.html
Purity
99.93
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
N#CC1=C(C2=CC=C(F)C=C2)N=C(N(C3=C(CC)N=C4C(C)=CC(N5CCN(CC(N6CC(O)C6)=O)CC5)=CN43)C)S1
Molecular Weight
588.70
References & Citations
[1]Desroy N, et al. Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis. J Med Chem. 2017 May 11;60(9):3580-3590.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101772/Ziritaxestat-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101772/Ziritaxestat-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1628260-79-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC219760L4V 200 µL
Claudin18 (CLDN18) (NM_001002026) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
MBS2071614-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Hypoxia Inducible Factor 2 Alpha (HIF2a)
Ask
View Details 
MBS2071614-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Hypoxia Inducible Factor 2 Alpha (HIF2a)
Ask
View Details MBS2071614-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Hypoxia Inducible Factor 2 Alpha (HIF2a)
Ask
View Details